论文部分内容阅读
目的探析厄贝沙坦和美托洛尔治疗心力衰竭的疗效。方法选取2015年5月~2016年4月我院收治的确诊心力衰竭患者100例作为研究对象,将其随机分为研究组和常规组,各50例。研究组采用厄贝沙坦结合美托洛尔进行治疗,常规组采用美托洛尔进行治疗,并观察两组患者的疗效、心功能改善情况等。结果研究组总有效率为86%,常规组总有效率为72%,差异有统计学意义(P<0.05)。结论采用厄贝沙坦联合美托洛尔治疗心力衰竭患者可有效提高疗效,且治疗性和安全性极高,值得临床推广应用。
Objective To investigate the efficacy of irbesartan and metoprolol in the treatment of heart failure. Methods From May 2015 to April 2016, 100 patients with confirmed heart failure admitted to our hospital were selected as study subjects and randomly divided into study group and conventional group, with 50 cases in each group. The study group was treated with irbesartan and metoprolol. The conventional group was treated with metoprolol, and the curative effect and cardiac function of the two groups were observed. Results The total effective rate was 86% in the study group and 72% in the conventional group, the difference was statistically significant (P <0.05). Conclusion Irbesartan combined with metoprolol in the treatment of patients with heart failure can effectively improve the efficacy, and the high therapeutic and safety, it is worthy of clinical application.